News Focus
News Focus
icon url

exwannabe

02/02/25 12:03 PM

#747049 RE: Investor082 #747045

You trust them after every carrots they have dangled over the last several years.


"Several"???

Combo trials were first put on the table seriously back in 2016. With 3 planned and one with details announced.
Direct was said to restart over 5 years ago and NWBO even paid cash to Cognate work it.
Bosch repeatedly disclosed Direct trials ready to launch at ASCO. as far back as 7 years ago.
FDA BLA submission was hoped for by 2009, yes that is 16 years ago. And that was based on the upcoming results of the P3 (then a P2).
icon url

dennisdave

02/02/25 12:20 PM

#747051 RE: Investor082 #747045

in the last 10Q NWBO stated they have contracted a third party to conduct joint trials with and engaged for a number of months in joint development of trial designs and selection of candidate cancers for a combination treatment clinical trial. Claiming thats a lie is absolutely BS

But I don’t agree with big pharma injecting cash. Rather NWBO will be diluting the shareholders in 2025 & 2026, just wait and watch.

thats physically impossible.

Also you contradict yourself. If Advent is that important to Powergrifter then she will make sure it has loads of work and to have loads of work they need to execute what was in the last 10Q + commercialize DCVAXL after UK approval. Again IMPOSSIBLE for a 29 cents stoc non revenue biotech to finance 500 million. IMPOSSIBLE